Nothing to See Here: FDA Issues Interchangeable Biosimilars Strategy Document September 25, 2026 By Sara W. Koblitz —

https://www.thefdalawblog.com/2026/09/nothing-to-see-here-fda-issues-interchangeable-biosimilars-strategy-document/?utm_source=rss&utm_medium=rss&utm_campaign=nothing-to-see-here-fda-issues-interchangeable-biosimilars-strategy-document One year after hosting a public workshop (“Advancing the Development of Interchangeable Products: Identifying Future Needs”), and as part of its BSUFA III commitments, FDA, on September 18, 2026, published for comment a strategy document entitled “BsUFA III Future Needs in the Development of Interchangeable Products Post-Workshop Strategy Document” (Strategy Document).